Skip to main content

INFECTIOUS DISEASE

Exhibiting 1,651 entries found in the GMN corpus.

YearTitle & TagsAuthor(s)
1723 CEA letter … containing, a comparison between the mortality of the natural small pox, and that given by inoculation.
1927 CEA leukoenkephalitis periaxialis concentricaról.
1965 CEA list of the original writings of Joseph Lord Lister, O.M.
1997 CEA melancholy scene of devastation: The public response to the 1793 Philadelphia yellow fever epidemic. Edited by J. Worth Estes and Billy G. Smith.
1911 CEA method for the pure cultivation of pathogenic Treponema pallidum (Spirochaeta pallida).
1909 CEA micro-organism which apparently has a specific relationship to Rocky Mountain spotted fever. A preliminary report.
1946 CEA microflocculation test for syphilis using cardiolipin antigen: preliminary report.
1901 CE​–1910 CEA monograph of the Culicidae, or mosquitoes. Mainly compiled from the collections received at the British Museum from various parts of the world in connection with the cause of malaria conducted by the Colonial Office and the Royal Society. 4 vols. and atlas.
1920 CEA more rapid and improved method of demonstrating spirochetes in tissues (Warthin and Starry’s cover-glass method).
1932 CEA morphological study of psittacosis virus, with the description of a developmental cycle.
1794 CEA narrative of the proceedings of the black people during the late awful calamity in Philadelphia, in the year 1793: and a refutation of some censures thrown upon them in some late publications.
1940 CEA neurotropic virus isolated from the blood of a native in Uganda.
1950 CEA new and practical B.C.G. skin test (the B.C.G. scarification test) for the detection of the total tuberculous allergy.
1934 CEA new antigen of B. typhosus. Its relation to virulence and to active and passive immunisation.
1919 CEA new generation of paratyphoid.
1974 CEA new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan.
1922 CEA new malaria parasite of man.
1900 CEA new pathogenic mould (formerly described as a protozoon: Coccidioides immitis pyogenes). Preliminary report.
2012 CEA new phlebovirus associated with severe febrile illness in Missouri.
2019 CEA new segmented virus associated with human febrile illness in China.
1969 CEA new series of 2-aminomethyltetrahydroquinoline derivatives displaying schistosomicidal activity in rodents and primates.
1941 CEA new serologically active phospholipid from beef heart.
1902 CEA new species of hookworm (Uncinaria americana) parasitic in man.
1982 CEA new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia.
1961 CEA new synthetic compound with antituberculous activity in mice; ethambutol (dextro-2, 2’-(ethylenediimino)-di-l-butanol).
THOMAS, J. P.
THOMAS, J. P.
& et al.
1720 CEA new theory of consumptions : more especially of a phthisis, or consumption of the lungs.
1937 CEA new tuberculin patch test.
1984 CEA new type of retrovirus isolated from patients presenting with lymphadenopathy and acquired immune deficiency syndrome: Structural and antigenic relatedness with equine infectious anemia virus.
1940 CEA new type of virus from epidemic influenza.
1996 CEA new variant of Creutzfeldt-Jakob disease in the UK.
1965 CEA new, active metabolite of ‘Miracil D’.
1990 CEA newly recognized fastidious gram-negative pathogen as a cause of fever and bacteremia.
1915 CEA note on a relapsing febrile illness of unknown origin.
1900 CEA note on the interval between infecting and secondary cases of yellow fever from the records of yellow fever at Orwood and Taylor, Mississippi, in 1898.
2003 CEA novel coronavirus associated with severe acute respiratory syndrome.
2013 CEA novel prion disease associated with diarrhea and autonomic neuropathy.
2000 CEA Plague of paradoxes: Aids, culture, and demography in Northern Tanzania.
1911 CEA plague-like disease of rodents.
1924 CEA plea for the early recognition of leprosy, with notes on diagnosis and methods.
1816 CEA practical account of the Mediterranean fever, as it appeared in the ships and hospitals of His Majesty's fleet on that station: With cases and dissections. To which are added facts and observations, illustrative of the causes, symptoms and treatment comprehending the history of the fever in the fleet, during the years 1810, 1811, 1813, and of the Gibraltar and Carthagena fevers.
1824 CEA practical essay on typhous fever.
1905 CEA preliminary note on the susceptibility of goats to Malta fever.
1906 CEA propos de l’impregnation au nitrate d’argent des spirochètes sur coupes.
1800 CE​–1802 CEA prospect of exterminating the small-pox, being the history of the variolae vaccinae, or kine-pox, commonly called the cow-pox; as it has appeared in England: With an account of a series of inoculations performed for the kine-pox in Massachusetts. [Part II:] A prospect of exterminating the small pox part II, being a continuation of a narrative of facts concerning the progress of the new inoculation in America; together with practical observations on the local appearance, symptoms, and mode of treating the variola vaccina, or kine pock; including some letters to the author, from distinguished characters, on the subject of this benign remedy, now passing with a rapid step through all ranks of society in Europe and America.
1906 CEA protozoon general infection producing pseudotubercles in the lungs and focal necroses in the liver, spleen and lymphnodes.
2019 CEA randomized, controlled trial of Ebola virus disease therapeutics.
1900 CEA recent observation on Filaria nocturna in Culex. probable mode of infection of man.
1924 CEA scarlet fever antitoxin.
2020 CEA sensory appendage protein protects malaria vectors from pyrethroids.
1933 CEA serological differentiation of human and other groups of hemolytic streptococci.